Clinical trial · Observational
Registry for Accelerated Partial Breast Irradiation With (SBRT) or (IMRT)
Accelerated Partial Breast Irradiation (PBI) With Stereotactic Body Radiation Therapy (SBRT) or Intensity Modulated Radiation Therapy (IMRT)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): A revised study has been listed here for us.
Summary
Brief summary (as posted)
This is a registry study that will be used to evaluate external beam radiation therapy methods for the accelerated treatment of breast cancer. Patients are being asked to take part in this registry because they have breast cancer and desire treatment with accelerated partial breast irradiation to be delivered by external beam methods.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radiation Therapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- SBRT
- description
- Patients treated with Stereotactic Body Radiation Therapy (SBRT)
- interventionNames
- Radiation: Radiation Therapy
- label
- IMRT
- description
- Patients treated with Intensity Modulated Radiation Therapy (IMRT)
- interventionNames
- Radiation: Radiation Therapy
Primary outcomes (1)
- measure
- Number of participants with treatment and toxicity-related adverse events as assessed by CTCAE v4.0".
- timeFrame
- Through study completion, an average of 12 months
- description
- Toxicity will be assessed using the CTCAEv4.0 and recorded.
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 50 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * Greater than or equal to 50 years old Low to intermediate DCIS Tumor size \< or = to 2cm Exclusion Criteria: * BRCA positive Lobular histology Angiolymphatic invasion
References
Publications (0)
Data not yet available